News related to
network

Oil loadings at Iran’s main crude export terminal appear to have stopped for several days, raising fresh concerns over Gulf supply as war pressure, shipping restrictions and environmental fears converge around Kharg Island. Commercial satellite imagery showed no ocean-going oil tankers at the island’s loading jetties on May 8, 9 or 11, marking the clearest sign so far of an extended interruption at the facility that handles […]

Arabian Post Staff -Dubai Abu Dhabi has moved to tighten control over its infrastructure delivery pipeline with a unified governance framework designed to cut approval delays, improve coordination and accelerate capital projects across the emirate. The Abu Dhabi Projects and Infrastructure Centre announced the framework on the opening day of the Abu Dhabi Infrastructure Summit 2026, bringing 14 government entities into a common mechanism covering municipalities, utilities, […]

HONG KONG SAR – Media OutReach Newswire – 12 May 2026 – G2E Asia + Asian IR Expo opens today at The Venetian Macao, bringing together global leaders across gaming, entertainment, and integrated resorts as digital innovation continues to reshape the industry’s next phase of growth.

Taking place from May 12-14, 2026, the co-located events are expected to welcome 8,000 industry professionals from over 90 countries and regions. Spanning more than 30,000 sqm, the exhibition features over 150 brands showcasing next-generation technologies, immersive solutions, and digital infrastructure across the sector.

Against the backdrop of an estimated ~8% annual growth trajectory in Asia’s integrated resorts sector, according to a 2025 report by Research and Markets, the event underscores the region’s accelerating role as a global growth engine, where technology innovation and rising demand are increasingly converging.

Reflecting this shift, “Asia’s integrated resorts sector is entering a pivotal phase of transformation, as markets across the region continue to evolve with a broader mix of tourism, entertainment and lifestyle experiences,” said Yip Je Choong, Senior Vice President, Commercial, APAC, RX (Reed Exhibitions). “With G2E Asia and Asian IR Expo co-located, we are creating a platform that brings together stakeholders across the value chain to support innovation, collaboration and long-term, sustainable growth.”

Across the exhibition floor and conference programs, key industry leaders are actively engaging with peers to exchange insights and explore new opportunities for collaboration.

Leading Industry Figures Mark Opening Ceremony

The opening ceremony, held in the Expo Hall, officially marked the commencement of G2E Asia + Asian IR Expo 2026, with senior industry figures from across gaming, hospitality, and entertainment in attendance.

Guests included: (List to be provided)

Their participation reflects the industry’s sustained engagement and long-term commitment to advancing innovation across integrated resorts, gaming, and entertainment ecosystems.

Conference Programs Led by Global Industry Voices

G2E Asia and Asian IR Expo each feature dedicated three-day programs led by senior industry figures addressing technologies, regulations, and market forces shaping the sector’s future.

On Tuesday, May 12, Mr. Grant Chum, Chief Executive Officer and Executive Director of Sands China Ltd., delivers the opening keynote for G2E Asia Conference and Asian IR Summit, setting the strategic tone with insights into global industry trends shaping gaming and entertainment.

On Thursday, May 14, Mr. Mario Yau Kwan Ho, Chairman and Co-Chief Executive Officer of NIP Group INC., and Co-owner of Boston Celtics, is set to present a keynote for Asian IR Summit, offering perspectives on global market shifts and the evolving integrated resorts landscape.

Across both programs, speakers include:

  • Mr. Adrian Lee, Head of Sales, Google Customer Solutions, Hong Kong & Macau, Google
  • Mr. AI Watson, Chief Executive Officer, Dataworks Group
  • Mr. Alan Teo, Chief Executive Officer, Hoiana Resort & Golf
  • Mr. Cheng Wai Tong, Deputy Director, Macao Government Tourism Office
  • Mr. Gregory Hawkins, President and Chief Operating Officer, Solaire
  • Mr. Joseph Bufalino, Executive Director of Responsible Gambling, Marina Bay Sands
  • Mr. Kenneth Feng, Chief Executive Officer and Executive Director, MGM China Holdings Limited
  • Mr. Walt Power, Chief Executive Officer, The Grand Ho Tram
  • And more.

Event Highlights Across May 12-14

Across three days, the co-located event presents a curated ecosystem of exhibition, education, and industry networking experiences.

Exhibition (May 12-14)
Discover innovation across gaming, entertainment, and integrated resorts, with more than 150 brands spanning the full industry ecosystem.

G2E Asia Conference (May 12-14)
Access critical market insights, regulatory developments, and business opportunities across Asia from the region’s leading platform for gaming and entertainment leaders.

Asian IR Summit (May 12-14)
Explore strategic insights across hospitality, technology, sports, and entertainment with senior leaders across the evolving integrated resorts sector.

Tech Talk (May 12)
Gain actionable insights from leading experts on leveraging Artificial Intelligence, applying Machine Learning in real-world operations, and using data to drive smarter, more profitable decisions.

May 12 Slots Networking:
Engage in exclusive roundtables for slots operators and suppliers to co-design next-generation gaming cabinets with embedded biometric feedback.

May 12 G2E Asia After Party:
Unwind with industry peers at a Venetian-themed gala featuring a live preview of 2027’s most anticipated VR casino suite.

May 13 Table Games Networking:
Exchange insights between operators and providers on gameplay evolution, innovation, and future table game ecosystems.

Be Part of the Future of Entertainment and Integrated Resorts

Industry professionals from gaming, entertainment, and integrated resorts sectors – including operators, providers, and hospitality experts – will gain strategic insights, networking opportunities, and explore cutting-edge innovations that are shaping the future of the sector.

Registration is available online and onsite.

To learn more about G2E Asia, visit www.G2EAsia.com.
To learn more about Asian IR Expo, visit www.AsianIRExpo.com.

Hashtag: #G2EAsia #AsianIRExpo2026

The issuer is solely responsible for the content of this announcement.

World-First Innovations Showcase Hong Kong’s Thriving Life and Health Tech Ecosystem from Bench to Bedside

HONG KONG SAR – Media OutReach Newswire – 12 May 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP) joined alongside 38 Park companies in the two flagship events of the 5th International Healthcare Week — the Hong Kong International Medical and Healthcare Fair (“Medical Fair”) and the Asia Summit on Global Health (“ASGH”), held from 11 – 13 May. Showcasing at these premier medical innovation and technology (I&T) events, HKSTP is demonstrating its pivotal role in nurturing and supporting the growth of biotechnology enterprises. During ASGH, HKSTP also hosted a dedicated investor pitch session, providing Park companies with an exclusive stage to connect directly with global capital and pursue fundraising opportunities.

HKSTP joined Medical Fair and Asia Summit on Global Health with 38 Park companies, comprehensively demonstrating the diverse strengths of Hong Kong's life and health technology sector as it progresses from R&D to commercial application.
HKSTP joined Medical Fair and Asia Summit on Global Health with 38 Park companies, comprehensively demonstrating the diverse strengths of Hong Kong’s life and health technology sector as it progresses from R&D to commercial application.

Over 30 Market-Ready Solutions across Four Key Industry Focus

On the opening day of the Medical Fair, the HKSTP pavilion drew numerous industry professionals, investors and professional buyers, who gathered to explore Hong Kong’s latest I&T achievements and actively discuss collaboration opportunities. Participating companies span four critical areas — health monitoring, surgical assistance, precision medicine, rehabilitation training — comprehensively demonstrating the diverse strengths of Hong Kong’s life and health technology sector as it progresses from research and development (R&D) to commercial application.

Mr Terry Wong, CEO of HKSTP, said: “HKSTP has always been a steadfast partner to tech ventures, building a vibrant and well-established ecosystem for biotech companies ranging from start-ups with early-stage innovation to experienced innovators with market-ready solutions. To meet their diverse needs, we offer end-to-end support from R&D to clinical applications, including lab facilities, funding connections and market expansion. Our presence at this event fully reflects the innovative vitality and strength of Hong Kong’s life and health tech ecosystem. We hope to showcase Hong Kong’s cutting-edge medical R&D achievements to the international community, while delivering a clear message: Hong Kong is not only a top-tier scientific research base, but also the strongest springboard for technology enterprises to go global. By uniting forces across all sectors, we will further solidify Hong Kong’s leadership as an international health tech hub.”

Park company Highlights:

  • Endovision offers an intestinal endoscopic imaging system that leverages AI and real-time imaging to assist physicians in conducting more precise examinations. The solution has already obtained EU Medical Device Regulation (MDR) certification.
  • Mirror Caring presents SyncKnee, a smart wearable solution integrating flexible sensors, embedded systems and AI analytics to deliver real-time monitoring of knee joint health and data-driven insights.
  • Voice Empowerment Technology features a customised “AI Voice Reconstruction Tool” designed to enhance the efficiency of speech therapy services, offering breakthrough communication support for patients with aphasia and speech disorders.

“World-First” Cutting-Edge Medical Technologies Take Centre Stage

This year, HKSTP has also set up a dedicated exhibition zone at the Asia Summit on Global Health (ASGH), spotlighting a range of groundbreaking biomedical solutions, including several “world-first” innovations:

  • Agilis Robotics: The world’s first robotic-assisted “En Bloc Transurethral Resection of Bladder Tumour”, achieving precise tumour resection margins and offering a minimally invasive surgical option with faster recovery for early-stage cancer patients.
  • GenEditBio: The world’s first in vivo genome editing therapy (often referred to as “DNA surgery”) targeting corneal dystrophy, with Phase I clinical trials expected to commence this year, aiming to improve patients’ quality of life.
  • Meta Pharmaceuticals: The world’s first oral inhibitor for treating autoimmune diseases such as inflammatory bowel disease and multiple sclerosis, enhancing medication convenience and delivering safer, more effective anti-inflammatory therapy.

Dedicated Investor Pitch Session: Connecting Global Capital to Accelerate Enterprise Growth

For early-stage biotech companies, funding is crucial to sustaining research and achieving breakthroughs. To this end, HKSTP is fulfilling its role as a “super-connector” by hosting the “Life and Health Technology Innovation Pitch” at ASGH, to bridge between Park companies and the global market and deepen international partnerships.

HKSTP hosted the "Life and Health Technology Innovation Pitch" session, providing Park companies with an exclusive stage to connect directly with 12 global investors and pursue fundraising opportunities.
HKSTP hosted the “Life and Health Technology Innovation Pitch” session, providing Park companies with an exclusive stage to connect directly with 12 global investors and pursue fundraising opportunities.

The pitch session bought together 12 leading global investors from the UK, the US, Singapore, Canada and beyond, creating a top-tier platform for fundraising and business matching, and accelerating the translation of life and health tech innovations. Ten Park companies with breakthrough technologies took the stage to attract international capital, further showcase their innovative solutions and advance to the next stage of growth and global expansion.

Event Details:
Hong Kong International Medical and Healthcare Fair (Medical Fair)
Date: 11–13 May 2026
Venue: Hong Kong Convention and Exhibition Centre, Hall 3DE
HKSTP Booth: 3E-E06

Asia Summit on Global Health (ASGH)
Date: 11–12 May 2026
Venue: Hong Kong Convention and Exhibition Centre, Hall 3FG
HKSTP Booth: 3F-A11
Hashtag: #HKSTP

The issuer is solely responsible for the content of this announcement.

About Hong Kong Science and Technology Parks Corporation

Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 17,000 research professionals and over 2,500 technology companies from 26 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.

Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.

Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.

Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in establishing I&T as a pillar of growth for Hong Kong.

More information about HKSTP is available at .

Android users across parts of Europe face a sharper mobile-fraud threat after a redesigned TrickMo variant began targeting banking, fintech, cryptocurrency wallet and authenticator applications with stronger stealth, persistence and network-control features. The malware, tracked as TrickMo C, does not appear to be a wholly new family. It is an overhaul of a known Android banking trojan that has been under active development for years, with its […]

Etihad Rail has moved into the final stage of preparations for the launch of passenger services later this year, marking a decisive shift in the UAE’s long-running plan to build a national rail system linking major cities, ports, industrial centres and residential hubs. Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Chairman of Etihad Rail, reviewed progress on the company’s freight and passenger operations during a meeting […]

Abu Dhabi has unveiled a AED55 billion public-private partnership pipeline, setting out 24 projects across transport, core infrastructure and social facilities that are expected to enter the market through 2026 and 2027. The programme, launched by the Abu Dhabi Investment Office and the Abu Dhabi Projects and Infrastructure Centre, marks one of the emirate’s largest structured openings to private capital in public infrastructure. It is designed to […]

Advertisements

Securing Maryland-Based Drug-Substance Facility and Existing Commercial Orders to Scale the Group’s Integrated Technology Platform

HONG KONG SAR – Media OutReach Newswire – 12 May 2026 – Bora Pharmaceuticals (“Bora” or “Bora Group”; TWSE: 6472; OTCQX: BORAY) today announced that its Board of Directors has approved the acquisition of the GMP manufacturing operations, including the CDMO business, of MacroGenics, Inc. (NASDAQ: MGNX), for total consideration of US$122.5 million, subject to customary working capital adjustments, and a contingent consideration of up to $5 million based on future customer orders. The transaction includes a biologics drug substance manufacturing facility located in Rockville, Maryland and an associated warehousing center in Frederick, Maryland. Upon closing of the acquisition, the Company will sign a long-term CDMO Service Agreement with MacroGenics.

Following closing, Bora Group intends to leverage the Rockville Site in cooperation with Tanvex Biopharma (TWSE: 6541), which operates the Group’s biologics CDMO franchise under the “Bora Biologics” brand. Together with Bora’s sterile drug product capabilities, this is expected to scale the Group’s end-to-end biologics platform.

The Rockville facility has operated as an outsource manufacturing partner since 2022 and is equipped with five 2,000-liter and two 500-liter single-use bioreactors and fully integrated QC and analytical laboratories and has been inspected by both the U.S. FDA and Japan’s PMDA. From the transaction, Bora is expected to assume a substantial backlog for the size of its Bora Biologics CDMO business, including commercial-stage monoclonal antibody programs, clinical-stage programs, and a strong project pipeline. Commercial manufacturing currently accounts for more than half of the site’s revenue.

“This acquisition marks a pivotal step in strengthening Bora’s integrated biologics CDMO platform in the United States”, said Bobby Sheng, Chairman and CEO of Bora Group. “With the addition of the Rockville site, Bora Biologics total drug substance capacity would be 20,000-liter (SUB) and Bora Group will integrate our in-house DS (Drug Substance) and DP (Drug Product) capabilities and network investments over the next 12 to 18 months to offer global biotech customers a seamless offering allowing customers to advance programs from development through commercial supply with one single partner.”

Bora’s Board of Directors has authorized the Chairman to finalize the transaction in line with market conditions and the regulatory environment. For the year ended December 31, 2025, MacroGenics reported contract manufacturing revenue of $52.6 million.
Hashtag: #BoraPharmaceuticals

The issuer is solely responsible for the content of this announcement.

About Bora:

Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.

By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.

For more, please visit:

Disclaimer:
This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.

Sharjah has approved a AED140 million bridge project on Mleiha Road to improve traffic movement at one of the emirate’s important road connections, with work scheduled to begin immediately and completion targeted within one year. His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, cleared the project as part of continuing efforts to upgrade the emirate’s transport network and ease […]

Washington’s push to regulate digital assets has entered a sharper phase after Senator Bernie Moreno accused major banks of trying to block stablecoin competition as Congress prepares for a decisive test of the CLARITY Act this week. Moreno, a Republican from Ohio and one of the Senate’s most vocal crypto advocates, said the “banking cartel” was “in full panic mode” over legislation that could reshape the relationship […]

Cybersecurity teams are tracking a stealthy espionage-style malware operation that uses GitHub Releases to hide a Python-based infostealer behind humanitarian-themed phishing material aimed at Russian-speaking targets. The campaign, tracked as Operation HumanitarianBait, begins with phishing emails carrying a RAR archive that contains a malicious Windows shortcut file. The lure presents itself as a Russian-language humanitarian aid request or application form, exploiting a sensitive social context while keeping […]

Arabian Post Staff -Dubai e& and Qualcomm Technologies have deepened their technology partnership with a plan to develop AI-powered autonomous systems for robotics, drones and other physical platforms across the UAE, placing edge computing and intelligent connectivity at the centre of the country’s next phase of industrial digitalisation. Central to the collaboration is a Next-Gen Autonomous Management Platform for Physical AI, designed to combine e&’s connectivity infrastructure […]

  Cybercriminals have used artificial intelligence to identify and weaponise a previously unknown software flaw, marking a significant escalation in the use of AI for offensive cyber operations. The attempted campaign targeted a widely used open-source, web-based system administration tool and centred on a zero-day vulnerability that could bypass two-factor authentication when valid user credentials were already available. The operation was disrupted before it could be used […]

Washington has widened the corporate stakes around President Donald Trump’s China visit by inviting Elon Musk and Apple chief executive Tim Cook to join a business delegation accompanying him to Beijing for talks with President Xi Jinping. The trip, scheduled around high-level meetings on May 14 and 15, is being shaped as a test of whether the world’s two largest economies can stabilise a relationship strained by […]

Dubai has honoured more than 47 Al Safeer Congress Ambassadors for helping attract international and regional business events, reinforcing the emirate’s drive to turn knowledge exchange into a core pillar of economic growth. The annual gala, organised by Dubai Business Events, the city’s official convention bureau under the Dubai Department of Economy and Tourism, took place at The Lana, Dorchester Collection, Dubai. The ceremony recognised ambassadors whose […]

Binance Bahrain has renewed its ISO/IEC 27001 and ISO/IEC 27701 certifications, strengthening its information security and privacy credentials as regulated crypto platforms face rising scrutiny over user protection, operational resilience and compliance standards across the Gulf. The Manama-based crypto asset platform said the renewed certifications cover its information security management and privacy information management systems. The development places data governance at the centre of its Bahrain operations, […]

SINGAPORE – Media OutReach Newswire – 11 May 2026 – The Institute of Singapore Chartered Accountants (ISCA) has launched a new Taskforce to strengthen financial reporting and investor confidence in Singapore, amid growing focus on corporate transparency, financial controls and trust in capital markets.

The Strengthening Financial Reporting Taskforce was launched today at the ISCA Value Unlock Forum held in partnership with Singapore Exchange (SGX). Chaired by Ms Euleen Goh, ISCA Distinguished Lifetime Member and Chairman of Singapore Institute of Management Group Ltd, the Taskforce will bring together leaders from business, finance, academia and investor groups to review Singapore’s financial reporting ecosystem and recommend ways to strengthen the quality, integrity and usefulness of corporate reporting.

The Taskforce comes at a timely moment as Singapore continues efforts to strengthen its capital markets and business ecosystem. Recent national initiatives, including the Accountancy Workforce Review Committee and the Monetary Authority of Singapore’s Equities Market Review, have highlighted the importance of strong financial reporting, professional capabilities and investor trust.

The launch also comes amid ongoing discussions on reducing compliance costs for smaller companies, including ACRA’s review of Singapore’s audit exemption framework. Regardless of how the framework evolves, strong financial reporting practices, competent finance professionals and effective financial controls remain fundamental to upholding confidence among investors, lenders and stakeholders.

The Taskforce will study how companies can improve the way they communicate financial performance, business risks and long-term value creation to investors and stakeholders. It will also examine how Singapore can continue to uphold high standards of governance, transparency and accountability in a rapidly evolving business environment.

Ms Euleen Goh, Chairperson of the Strengthening Financial Reporting Taskforce, said: “Financial reporting has always been the language of business. As markets evolve, it must speak more clearly and more usefully to the stakeholders who rely on it. The Taskforce will take a practical and holistic look at how Singapore can raise the bar so that companies communicate value and insights with the confidence and clarity that investors and the market expect.”

The Taskforce comprises leaders from across the financial ecosystem:

  • Mr Liew Nam Soon, Deputy Regional Managing Partner, EY Asia East; Managing Partner, EY Asean; Managing Partner, EY Singapore & Brunei
  • Mr Leong Yung Chee, Group CFO, United Overseas Bank Limited
  • Professor Lawrence Loh, Director, Centre for Governance and Sustainability, NUS Business School, National University of Singapore
  • Ms Belinda Tan, CA (Singapore), Managing Director of Finance, Temasek International
  • Mr Ang Hao Yao, Vice President, Securities Investors Association (Singapore)
  • Ms Karen Loon, Member, Governing Council of the Singapore Institute of Directors
  • Mr Tan Boon Gin, CEO, Singapore Exchange Regulation (Observer)
  • Mrs Chia-Tern Huey Min, CE, Accounting and Corporate Regulatory Authority (Observer)

Mr Lee Boon Teck, President of ISCA, said: “High-quality financial reporting and strong financial controls are essential to investor confidence and market integrity. As Singapore’s national accountancy body, ISCA believes professionally trained finance and accounting professionals play a critical role in safeguarding trust in business and capital markets. This Taskforce reflects our commitment to supporting Singapore’s continued standing as a trusted global financial and business hub.”

The Taskforce was launched at the ISCA Value Unlock Forum, which brought together C-suite leaders, finance professionals and capital markets stakeholders to discuss how companies can better communicate value to the market.

ISCA Academy, an Approved Training Provider under the SGX Value Unlock Programme, supported the afternoon sessions as part of the ISCA Value Unlock Series. The series aims to equip listed companies and finance leaders with practical capabilities to communicate performance, strategy and value more effectively to the market.

Ms Cyndi Pei, Chairperson of ISCA Academy, said: “As stakeholder expectations continue to evolve, finance leaders are increasingly expected to go beyond reporting results to articulating performance, risks and value creation with clarity, credibility and context. ISCA Academy remains committed to supporting the profession and the broader market by building the practical capabilities needed to reinforce trust, promote transparency and strengthen confidence in Singapore’s capital markets.”

The Taskforce will engage stakeholders over the coming months and provide recommendations on strengthening Singapore’s financial reporting ecosystem.Hashtag: #ISCA #CharteredAccountants #FinancialReporting #DifferenceMakers #Accounting #Accountancy

The issuer is solely responsible for the content of this announcement.

About the Institute of Singapore Chartered Accountants (ISCA) Academy

The Institute of Singapore Chartered Accountants (ISCA) is the national accountancy body of Singapore. Established in 1963, ISCA administers the Singapore Chartered Accountant Qualification programme and is the designated entity by the Singapore Ministry of Finance to confer the Chartered Accountant of Singapore [CA (Singapore)] designation.

ISCA supports over 43,000 members across industries in Singapore and globally, with members in more than 40 countries. With a growing international presence, ISCA has 12 overseas chapters, 7 offices across 10 countries and a network of over 150 strategic partners, strengthening professional connections and opportunities across borders. ISCA is also a member of Chartered Accountants Worldwide, a global network representing more than 1.8 million Chartered Accountants and students across over 190 countries.

ISCA advances professional development and lifelong learning through ISCA Academy, its training arm and drives community impact through ISCA Cares, its charity arm.

ISCA Academy, the leading business school of ISCA, delivers immersive, industry-informed learning across accountancy, finance, technology, governance and leadership. We equip learners to reskill, reconnect and reinvent, empowering them to stay relevant and ahead by choice.

For more information, visit .

German and Spanish police have shut down a revived version of Crimenetwork, the German-speaking dark web marketplace that had re-emerged within days of its 2024 takedown, arresting a 35-year-old German citizen at his home in Mallorca under a European arrest warrant. The suspect, from the Recklinghausen district in North Rhine-Westphalia, is accused of building and administering a new technical infrastructure for Crimenetwork after the original platform was […]

Arabian Post Staff -Dubai Space42 has selected Skylo Technologies to provide standards-based direct-to-device connectivity through Thuraya-4, advancing plans to merge mobile satellite services with mainstream telecom networks across underserved land, sea and remote industrial zones. The Abu Dhabi-listed space technology company said the partnership will use Skylo’s 3GPP-compliant non-terrestrial network platform with Thuraya-4, Space42’s next-generation geostationary mobile communications satellite. The integration is designed to allow ordinary compatible […]

Arabian Post Staff -Dubai Al-Futtaim Engineering has completed a major mechanical, electrical and plumbing package at Dubai Exhibition Centre, strengthening the venue’s readiness for larger global exhibitions at Expo City Dubai. The company, part of Al-Futtaim Contracting, delivered the MEP scope for the Dubai Exhibition Centre within a nine-month programme, taking the project from site access to final commissioning and operational readiness. The development has secured Building […]

Saudi Arabia’s biodiversity record has expanded with Taibah University documenting a previously undescribed burrowing scorpion species from Harrat Uwayrid in AlUla Governorate, marking a notable addition to the Kingdom’s growing catalogue of desert wildlife. The species, formally named Scorpio furvus, was identified through a research effort led by Dr Abdulhadi Aloufi, Associate Professor of Ecology and Taxonomy at Taibah University, with collaborators from Jordan. The findings were […]

Alphabet has moved within striking distance of becoming the world’s most valuable company, as investor confidence in its artificial intelligence strategy reshapes Wall Street’s view of Google’s parent after years of concern that it had fallen behind rivals in the AI race. Shares of the company have surged this year, lifting its market value to about $4.86 trillion by the close of trading on May 8, 2026. […]

HONG KONG SAR – Media OutReach Newswire – 11 May 2026 – BeOne Medicines (BeOne, Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it has been named “Outstanding Global Oncology Company of the Year” at the HKCT Business Awards 2026. The award recognizes BeOne’s continued progress in research and development (R&D) and manufacturing of innovative cancer therapies, as well as its efforts to support broader patient access to medicines.

(Left) Richard Cheng, Associate Commercial Director (Hong Kong & Macau) at BeOne; (Right) Dr. Bernard Chan, JP, Under Secretary for Commerce and Economic Development
(Left) Richard Cheng, Associate Commercial Director (Hong Kong & Macau) at BeOne; (Right) Dr. Bernard Chan, JP, Under Secretary for Commerce and Economic Development

Richard Cheng, Associate Commercial Director (Hong Kong & Macau) at BeOne, said: “We are honored to receive this award from the Hong Kong Commercial Times. BeOne has built differentiated capabilities across clinical development and manufacturing, supported by a broad and diverse R&D pipeline. In Hong Kong, we have introduced several therapies, including BTK, PD-1 and IL-6 inhibitors. Looking ahead, we will continue to advance our plans in Hong Kong by leveraging opportunities enabled by the ‘1+’ policy and the planned establishment of the Hong Kong Centre for Medical Products Regulation (CMPR) and its ‘primary evaluation’ mechanism. Supported by our global supply network, we aim to bring additional medicines to patients in Hong Kong and the Greater Bay Area and help improve access to treatments aligned with international standards.”

Global R&D and Innovation

Founded in 2010, BeOne is focused on accelerating key stages of oncology innovation—from discovery through development to patient access. Through an integrated model spanning R&D, manufacturing and commercialization, the company works to translate innovation into clinical value. Today, BeOne operates across six continents in more than 45 markets and is supported by more than 1,200 oncology R&D professionals.

BeOne’s R&D platform has advanced more than 35 clinical-stage drug candidates, including three internally developed products that have received commercial approval, reaching more than 2 million patients worldwide.

Pipeline Highlights

BeOne continues to expand its global footprint through a portfolio of internally developed products, including:

  • BTK Inhibitor: As the company’s first self-developed innovative drug, it holds a significant position in the global market (including Hong Kong), particularly in the field of B-cell malignancies.
  • PD-1 Inhibitor: Launched in more than 50 markets worldwide, reaching 1.8 million people. In Hong Kong, it has been approved for six indications, including immunotherapy for lung, esophageal and gastric cancers.
  • Next-Generation BCL-2 Inhibitor: Approved for certain lymphoma indications in Mainland China. It has been granted Priority Review by the U.S. Food and Drug Administration, and a marketing application has been submitted in the European Union.

Manufacturing Network Supporting Global Supply

BeOne maintains an integrated chain from R&D to manufacturing and commercialization, supported by production sites in the United States and China designed to help maintain a stable global supply:

  • New Jersey, U.S.: A North America biologics hub integrating manufacturing and clinical R&D. The site spans 1.82 million square feet, including a dedicated 400,000-square-foot production facility.
  • Suzhou, China (small molecule manufacturing): Supports clinical and commercial-scale production in accordance with applicable FDA, EMA and GMP requirements.
  • Guangzhou, China (biologics and ADC manufacturing): A 1.3 million-square-foot facility supporting R&D and production of antibody-drug conjugates (ADCs) and serving as a supply hub for the Greater Bay Area, including Hong Kong.

BeOne has also been recognized by industry organizations for its innovation, including being named one of the “Top 10 Most Inventive” pharmaceutical companies by IDEA Pharma in 2025[1]. The company will continue to advance programs in hematologic malignancies and solid tumors, with Hong Kong serving as a strategic hub to support the delivery of innovative therapies globally.

1. 2025 Pharmaceutical Innovation and Invention Index, IDEA Pharma

This material is intended for the purpose of communicating disease-related knowledge and cutting-edge medical information to the public and is not intended for promotional or advertising purposes. It does not constitute a promotion or recommendation for any medication or treatment plan, nor can it serve as a substitute for the advice of medical and health professionals. If you have any questions, please consult a medical or health professional.

Forward-Looking Statement

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeOne’s plans, commitments, aspirations and goals related to BeOne’s medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled “Risk Factors” in BeOne’s most recent periodic report filed with the U.S. Securities and Exchange Commission (“SEC”) as well as discussions of potential risks, uncertainties, and other important factors in BeOne’s subsequent filings with the SEC. All information in this presentation is as of the date presented, and BeOne undertakes no duty to update such information unless required by law.For BeOne’s newsroom, please visit www.beonemedicines.com

Hashtag: #BeOneMedicines

The issuer is solely responsible for the content of this announcement.

About BeOne Medicines

BeOne Medicines is a global oncology company domiciled in Switzerland, focused on discovering and developing innovative treatments designed to be more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is advancing a diverse pipeline of novel therapeutics through internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to improving access to medicines for more patients. To learn more about BeOne, please visit and follow us on , , and .

About HKCT Business Awards 2026

Organized by the Hong Kong Commercial Times, the HKCT Business Awards is a representative annual event in the Hong Kong business community. It honors companies demonstrating excellence, innovation, and significant contributions to Hong Kong’s economy and society across dimensions including technological innovation and market competitiveness.

Arabian Post Staff -Dubai Classrooms across the UAE are set to reopen on Monday, May 11, after education authorities cleared the resumption of in-person learning for students, teachers and administrative staff following a temporary shift to remote classes linked to regional security developments. The decision covers public and private schools, nurseries, universities and higher education institutions across the country, restoring normal campus attendance after precautionary distance learning […]

VISHNU RAJA
RYO YAMADA
HITORI GOTOH
IKUYO KITA